Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | miRNA | Metafectene | publication | S. Guan, Dissertation, 2017, Ruprecht-Karls-Universität zu Heidelberg | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | S. T. Al Rashid et al., Cancer Res., Dec 2005; 65: 10810 - 10821 | Link | |||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., J. Biol. Chem., Jul 2013; 288: 21793 - 21801 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | X. Zhou et al., J. Biol. Chem., Jul 2013; 288: 21793 - 21801 | Link | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link | ||
HCT15 |
Human colon adenocarcinoma cell line | ATCC CCL-225 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HD-11 |
Chicken leukaemic macrophage cell line | Chicken | immune system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Berberich et al., FEBS Open Bio, 2017, 7: 1909–1923, doi:10.1002/2211-5463.12323 | Link | ||
HEC-1A |
Human endometrial carcinoma cell line | ATCC HTB-112 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | H. Kiaris et al., PNAS, Aug 2003; 100: 9512 - 9517 | Link | ||
HECa10 |
Mouse endothelial cells of peripheral lymph nodes | Mouse | immune system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | P. Janus et al., Cell Death & Differentiation, 2020, 27: 2280–2292, doi.org/10.1038/s41418-020-0501-8 | Link | ||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK-sGC |
Human embryonic kidney cell line, stably expressing human sGC (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Meurer et al., Circ. Res., Jul 2009; 105: 33 - 41 | Link | |||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | F. Steinberg et al., J. Biol. Chem., Nov 2010; 285: 37704 - 37715 | Link | |||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | Metafectene | publication | L. Zhuang et al., Archives of Biochemistry and Biophysics, 2017, 625-626: 54-64, http://dx.doi.org/10.1016/j.abb.2017.06.002 | |||||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Timsah et al., Nature Struct. & Mol. Biol., 2014, 21(2), doi:10.1038/nsmb.2752 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. P. Karpinar et al., EMBO J., Oct 2009; 28: 3256 - 3268 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Haar et al., Nucleic Acids Res., Feb 2016; 44: 1326 - 1341 | Link |